Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Producing Soluble Human Programmed Cell Death Protein-1: A Natural Supporter for Cd4+T Cell Cytotoxicity and Tumor Cells Apoptosis Publisher



Mohammadzadeh S1 ; Khanahmad H2 ; Esmaeil N1 ; Eskandari N1 ; Rahimmanesh I2 ; Rezaei A1 ; Andalib A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Genetics and Molecular Biology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Iranian Journal of Biotechnology Published:2019


Abstract

Background: Programmed cell death protein-1 (PD-1)/PD-L1 pathway is one of the immune checkpoint pathways involved in the regulation of the immune responses and the suppression of anti-tumor defense. PD-1/PD-L1 blocking antibodies improve immune responses such as cytotoxic activity of CD8+/CD4+T cells and increase mortality of tumor cells as well; however, their use is accompanied by adverse side effects. Objectives: We aimed to produce a native blocker of human PD-1/PD-L1, for developing T cells cytotoxicity and tumor cells apoptosis. Materials and Methods: We designed and cloned soluble human PD-1-GFP-pcDNA3.1/hygro construct in Escherichia coli strain TOP10 cells and then transfected this construct into the HEK cells. The concentration of the secreted shPD-1 in the supernatant was measured and the supernatant was used for blocking PD-L1 on the MDA-MB-231 cells. The cytotoxicity of CD8+/CD4+T cells and the apoptosis of MDA-MB-231 cells, under the influence of shPD-1 in the co-culture of T cells with the MDA-MB-231 cells, were evaluated using flow cytometry technique. Results: The GFP expression in the transfected cells illustrated the successful designing, transfection, and production of shPD-1. Soluble human PD-1 concentration in the supernatant of the transfected HEK cells was significantly higher than the untransfected cells. In addition, shPD-1 significantly blocked PD-L1 on the MDA-MB-231 cells, improved the cytotoxicity of CD4+T cells, and increased the apoptosis of MDA-MB-231 cells. Conclusion: Overall, increased CD4+T cell cytotoxicity and tumor cells apoptosis under the influence of shPD-1, confirmed the effectiveness of shPD-1 as a natural blocker of PD-L1and as an augmenter of the anti-tumor immune responses. © 2019 The Author(s).
Related Docs
View other Related Docs
1. Pd-1/Pd-L1 Interaction Regulates Bcl2, Ki67, Bax, and Casp3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid Leukemia, Iranian Journal of Allergy, Asthma and Immunology (2023)
2. Immunologic Tumor Microenvironment Modulators for Turning Cold Tumors Hot, Cancer Communications (2024)
3. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
4. Targeting Immune Checkpoints: How to Use Natural Killer Cells for Fighting Against Solid Tumors, Cancer Communications (2023)
5. Immune Checkpoint Inhibition for the Treatment of Cancers: An Update and Critical Review of Ongoing Clinical Trials, Clinical Immunology (2021)
6. In-Vivo Evaluation of Dt386-Br2, a Promising Anticancer Fusion Protein, in Mice Model, Journal of Isfahan Medical School (2017)
7. Construction and Periplasmic Expression of a Bispecific Tandem Scfv for Dual Targeting of Immune Checkpoints, Advanced Biomedical Research (2023)
8. An in Silico Investigation on the Binding Site Preference of Pd-1 and Pd-L1 for Designing Antibodies for Targeted Cancer Therapy, PLoS ONE (2024)
Experts (# of related papers)
View all Related Experts
Mazdak Ganjalikhani Hakemi (5)
Vajihe Akbari (3)
Other Related Docs
9. Combination Therapy With Nivolumab (Anti-Pd-1 Monoclonal Antibody): A New Era in Tumor Immunotherapy, International Immunopharmacology (2022)
10. Inhibition of Phosphodiestrase 9 Induces Cgmp Accumulation and Apoptosis in Human Breast Cancer Cell Lines, Mcf-7 and Mda-Mb-468, Cell Proliferation (2012)
11. Research Paper: Immune Checkpoint Molecules in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System, Basic and Clinical Neuroscience (2020)
12. The Role of Tim-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?, Frontiers in Oncology (2020)
13. A-Ngr Fusion Protein Induces Apoptosis in Human Cancer Cells, EXCLI Journal (2018)
14. In Vitro Selective Depletion of Cd4+Cd25+ Regulatory T-Cells From Pbmc Using Anti-Tac-Sap, Journal of Immunotoxicology (2012)
15. Production and Evaluation of In-Vitro and In-Vivo Effects of P28-Il24, a Promising Anti-Breast Cancer Fusion Protein, International Journal of Peptide Research and Therapeutics (2021)
16. Strong Capacity of Differentiated Pd-L1 Car-Modified Ucb-Cd34+ Cells and Pd-L1 Car-Modified Ucb-Cd34+-Derived Nk Cells in Killing Target Cells and Restoration of the Anti-Tumor Function of Pd-1-High Exhausted T Cells, Stem Cell Research and Therapy (2024)
17. Immunogenic Cell Death Inducer Peptides: A New Approach for Cancer Therapy, Current Status and Future Perspectives, Biomedicine and Pharmacotherapy (2023)
18. Improved Anti-Treg Vaccination Targeting Foxp3 Efficiently Decreases Regulatory T Cells in Mice, Journal of Immunotherapy (2016)
19. Nivolumab Plus Ipilimumab Combination Therapy in Cancer: Current Evidence to Date, International Immunopharmacology (2023)
20. Tim3 and Pd-1 As a Therapeutic and Prognostic Targets in Colorectal Cancer: Relationship With Sidedness, Clinicopathological Parameters, and Survival, Frontiers in Oncology (2023)
21. Development of a Stable Cell Line, Overexpressing Human T-Cell Immunoglobulin Mucin 1, Iranian Journal of Biotechnology (2015)
22. Pd-L1 Stimulation Can Promote Proliferation and Survival of Leukemic Cells by Influencing Glucose and Fatty Acid Metabolism in Acute Myeloid Leukemia, BMC Cancer (2023)